University of Minnesota researchers in the Institute for Molecular Virology (IMV) have made a key discovery that could have important implications for developing a strategy to stop the spread of a highly infectious virus currently spreading among remote areas of central Australia. Called human T-cell leukemia virus type 1 (HTLV-1), infection rates are reportedly exceeding 40 percent among adults in those communitites. HTLV-1, the first human cancer virus discovered, can cause leukemia and lymphoma.
Shelley N. Grimes, PhD, an associate professor in the Department of Diagnostic and Biological Sciences at the University of Minnesota School of Dentistry, passed away on March 20. She was 54.
In a study published online in the Journal of Virology, University of Minnesota scientists in the School of Dentistry-based Institute for Molecular Virology, analyzed seven different retrovirues, including two types of HIV as well as HTLV-1, a virus that causes T-cell leukemia. They found that no two kinds of retroviruses look -- or act -- the same.
Louis Mansky PhD, a University of Minnesota School of Dentistry professor and director of the Institute for Molecular Virology, joined with other University of Minnesota and Emory University researchers on a project which may lead to a more cost-effective option for HIV medication.
School of Dentistry researchers Louis Mansky, Director of the Institute for Molecular Virology, and Wei Zhang recently captured 3-D images of the human T-cell leukemia virus type 1 (HTLV-1) through advanced electron imaging, a technology that enabled them to study the virus particles in more detail than before.